Such innovative methods are needed at a time when the COVID-19 pandemic highly impacted diabetes care worldwide with a drop in access to insulin, decreased admission to hospital for patients in need of professional care, and many outpatient clinics shutting down [77]. This evidence concerns the gene INS and diabetes mellitus.